Potential Benefits of Ticagrelor beyond Platelet Inhibition

Publisher： Karger

E-ISSN： 1421-9751|125|1|31-33

ISSN： 0008-6312

Source： Cardiology, Vol.125, Iss.1, 2013-04, pp. : 31-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ticagrelor

By  

PRACTICAL DIABETES (INCORPORATING CARDIABETES), Vol. 33, Iss. 7, 2016-09 ,pp. : 258-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dyspnea and Reversibility of Antiplatelet Agents: Ticagrelor, Elinogrel, Cangrelor, and Beyond

By  

Cardiology, Vol. 127, Iss. 1, 2013-10 ,pp. : 20-24

Karger

Access to resources Recommend Favorite

Anagrelide platelet‐lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 4, 2015-04 ,pp. : 631-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

High on‐treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta‐analysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 931-942

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets

By  

TRANSFUSION, Vol. 55, Iss. 6, 2015-06 ,pp. : 1320-1326

John Wiley & Sons Inc

Access to resources Recommend Favorite